help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wehrenberg, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wehrenberg, W. B.

Endocrinology, Vol 118, 489-494, Copyright © 1986 by Endocrine Society

ARTICLES

The role of growth hormone-releasing factor and somatostatin on somatic growth in rats

WB Wehrenberg

The role of GH-releasing factor (GRF) in regulating somatic growth was studied in rats by passively immunizing animals with antisera raised against rat GRF. GRF antiserum (GRF-ab) treatment significantly inhibited the normal increase in body weight observed in both young male and female rats. Similar studies conducted in neonatal rats (days 1-23 of age) also demonstrated that GRF is critical in regulating neonatal growth. The biological half-life of the GRF-ab was determined to be between 2.5 and 3.5 days in these animals. The effects of GRF-ab and somatostatin antiserum (SRIF-ab) treatment on serum GH concentrations were also studied in neonatal rats. Between 1 and 20 days of age, GRF-ab treatment significantly decreased serum GH concentrations compared to those in control animals. From days 1-10 of age, SRIF-ab treatment had no effect on GH concentrations, whereas on days 15 and 20 of age, SRIF-ab treatment significantly increased GH concentrations. The results demonstrate that hypothalamic GRF is critical in regulating serum GH concentrations and somatic growth in neonatal and young animals. They also suggest that the role of SRIF in regulating GH concentrations is not established until sometime after 10 days of age.


This article has been cited by other articles:


Home page
 FASEB J.Home page
H. MORGAN, M. SMITH, Z. BURKE, and D. CARTER
The transactivation-competent carboxyl-terminal domain of AF-9 is expressed within a sexually dimorphic transcript in rat pituitary
FASEB J, June 1, 2000; 14(9): 1109 - 1116.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
D. K. Reed, A. I. Korytko, R. W. Hipkin, W. B. Wehrenberg, A. Schonbrunn, and L. Cuttler
Pituitary Somatostatin Receptor (sst)1-5 Expression during Rat Development: Age-Dependent Expression of sst2
Endocrinology, October 1, 1999; 140(10): 4739 - 4744.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
S. X. Simonian, H. E. Murray, G. E. Gillies, and A. E. Herbison
Estrogen-Dependent Ontogeny of Sex Differences in Somatostatin Neurons of the Hypothalamic Periventricular Nucleus
Endocrinology, March 1, 1998; 139(3): 1420 - 1428.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
N. Nogues, J. A. Del RIo, M. Perez-Riba, E. Soriano, R. A. Flavell, and A. Boronat
Placenta-Specific Expression of the Rat Growth Hormone-Releasing Hormone Gene Promoter in Transgenic Mice
Endocrinology, August 1, 1997; 138(8): 3222 - 3227.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. Wells, D. M. Flavell, S. E. Wells, D. F. Carmignac, and I. C. A. F. Robinson
Effects of Growth Hormone Secretagogues in the Transgenic Growth-Retarded (Tgr) Rat
Endocrinology, February 1, 1997; 138(2): 580 - 587.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society